-
2
-
-
0028929803
-
Angiogenesis in cancer, vascular, rheumatoid and other diseases
-
Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nature Med 1995; 1, 27-31.
-
(1995)
Nature Med
, vol.1
, pp. 27-31
-
-
Folkman, J.1
-
3
-
-
0027043136
-
Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma
-
Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992; 84, 1875-1887.
-
(1992)
J Natl Cancer Inst
, vol.84
, pp. 1875-1887
-
-
Weidner, N.1
Folkman, J.2
Pozza, F.3
-
4
-
-
0026497186
-
Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer
-
Horak ER, Leek R, Klenk N, et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. The Lancet 1992; 340, 1120-1124.
-
(1992)
The Lancet
, vol.340
, pp. 1120-1124
-
-
Horak, E.R.1
Leek, R.2
Klenk, N.3
-
5
-
-
0028939826
-
Clinical importance of the determination of tumor angiogenesis in breast carcinoma: Much more than a new prognostic tool
-
Gasparini G, Harris AL. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. [Review]. J Clin Oncol 1995; 13, 765-782.
-
(1995)
J Clin Oncol
, vol.13
, pp. 765-782
-
-
Gasparini, G.1
Harris, A.L.2
-
6
-
-
0029166443
-
Regulation of the expression of the VEGF/VPS and its receptors: Role in tumor angiogenesis
-
Kolch W, Martiny-Baron G, Kieser A, Marme D. Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis. Breast cancer Res Treat 1995; 36, 139-155.
-
(1995)
Breast Cancer Res Treat
, vol.36
, pp. 139-155
-
-
Kolch, W.1
Martiny-Baron, G.2
Kieser, A.3
Marme, D.4
-
7
-
-
0028954492
-
Enhancement of tumor growth and vascular density by transfection of vascular endothelial growth factor into MCF-7 human breast carcinoma cells
-
Zhang HT, Craft P, Scott PA, et al. Enhancement of tumor growth and vascular density by transfection of vascular endothelial growth factor into MCF-7 human breast carcinoma cells. J Natl Cancer Inst 1995; 87, 213-219.
-
(1995)
J Natl Cancer Inst
, vol.87
, pp. 213-219
-
-
Zhang, H.T.1
Craft, P.2
Scott, P.A.3
-
8
-
-
0030004485
-
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
-
Ferrara N, Carver-Moore K, Chen H, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380, 439-442.
-
(1996)
Nature
, vol.380
, pp. 439-442
-
-
Ferrara, N.1
Carver-Moore, K.2
Chen, H.3
-
9
-
-
0029985805
-
Quantitative analysis of vascular endothelial growth factor in primary breast cancer
-
Toi M, Kondo S, Suzuki H, et al. Quantitative analysis of vascular endothelial growth factor in primary breast cancer. Cancer 1996; 77, 1101-1106.
-
(1996)
Cancer
, vol.77
, pp. 1101-1106
-
-
Toi, M.1
Kondo, S.2
Suzuki, H.3
-
10
-
-
0031966682
-
Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma
-
Imoto H, Osaki T, Taga S, et al. Vascular endothelial growth factor expression in non-small-cell lung cancer: prognostic significance in squamous cell carcinoma. J Thoracic Cardiovasc Surg 1997; 115, 1007-1014.
-
(1997)
J Thoracic Cardiovasc Surg
, vol.115
, pp. 1007-1014
-
-
Imoto, H.1
Osaki, T.2
Taga, S.3
-
11
-
-
0031024216
-
Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma
-
Inoue K, Ozeki Y, Suganuma T, et al. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Cancer 1997; 79, 206-213.
-
(1997)
Cancer
, vol.79
, pp. 206-213
-
-
Inoue, K.1
Ozeki, Y.2
Suganuma, T.3
-
12
-
-
1842335671
-
Coexpression of VEGF and bFGF in human epidermoid lung carcinoma is associated with increased vessel density
-
Mattern J, Koomägi R, Volm M. Coexpression of VEGF and bFGF in human epidermoid lung carcinoma is associated with increased vessel density. Anticancer Res 1997; 17, 2249-2252.
-
(1997)
Anticancer Res
, vol.17
, pp. 2249-2252
-
-
Mattern, J.1
Koomägi, R.2
Volm, M.3
-
13
-
-
0030969559
-
Vascular endothelial growth factor os associated with neovascularization and influences progression of non-small lung carcinoma
-
Fontanini G, Vignati S, Boldrini L, et al. Vascular endothelial growth factor os associated with neovascularization and influences progression of non-small lung carcinoma. Clin Cancer Res 1997; 3, 861-865.
-
(1997)
Clin Cancer Res
, vol.3
, pp. 861-865
-
-
Fontanini, G.1
Vignati, S.2
Boldrini, L.3
-
14
-
-
0030066037
-
Prognostic value of vascular endothelial growth factor expression in gastric carcinoma
-
Maeda K, Chung YS, Ogawa Y, et al. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 1996; 77, 858-863.
-
(1996)
Cancer
, vol.77
, pp. 858-863
-
-
Maeda, K.1
Chung, Y.S.2
Ogawa, Y.3
-
15
-
-
0030817612
-
Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: Correlation with clinicopathology and patient survival, and analysis of serum VEGF levels
-
Yamamoto S, Konishi I, Mandai M, et al. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels. Br J Cancer 1997; 76, 1221-1227.
-
(1997)
Br J Cancer
, vol.76
, pp. 1221-1227
-
-
Yamamoto, S.1
Konishi, I.2
Mandai, M.3
-
16
-
-
84970070220
-
Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancer
-
Takahashi Y, Takahashi Y, Mai M, et al. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancer. Cancer Res 1995; 55, 3964-3968.
-
(1995)
Cancer Res
, vol.55
, pp. 3964-3968
-
-
Takahashi, Y.1
Takahashi, Y.2
Mai, M.3
-
17
-
-
0030997316
-
Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor and vascular endothelial growth factor in sera of cancer patients
-
Dirix LY, Vermeiden PB, Pawinski A, et al. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor and vascular endothelial growth factor in sera of cancer patients. Br J Cancer 1997; 76, 238-243.
-
(1997)
Br J Cancer
, vol.76
, pp. 238-243
-
-
Dirix, L.Y.1
Vermeiden, P.B.2
Pawinski, A.3
-
18
-
-
0031051066
-
Serum vascular endothelial growth factor (VEGF), a prognostic indicator in sarcoma and carcinoma patients
-
Heits F, Katschinsky DM, Wiedemann GJ, et al. Serum vascular endothelial growth factor (VEGF), a prognostic indicator in sarcoma and carcinoma patients. Int J Oncol 1997; 10, 333-337.
-
(1997)
Int J Oncol
, vol.10
, pp. 333-337
-
-
Heits, F.1
Katschinsky, D.M.2
Wiedemann, G.J.3
-
19
-
-
0030797765
-
A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma
-
Salven P, Teerenhovi L, Joensuu H. A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma. Blood 1997; 90, 3167-3172.
-
(1997)
Blood
, vol.90
, pp. 3167-3172
-
-
Salven, P.1
Teerenhovi, L.2
Joensuu, H.3
-
20
-
-
1842409593
-
Serum vascular endothelial growth factor is often elevated in disseminated cancer
-
Salven P, Maäenpää H, Orpana A, et al. Serum vascular endothelial growth factor is often elevated in disseminated cancer. Clin Cancer Res 1997; 3, 647-651.
-
(1997)
Clin Cancer Res
, vol.3
, pp. 647-651
-
-
Salven, P.1
Maäenpää, H.2
Orpana, A.3
-
21
-
-
0031942430
-
High pretreatment serum levels of vascular endothelial growth factor (VEGF) is associated with poor outcome in small cell lung cancer
-
Salven P, Routsalainen T, Mattson K, Joensuu H. High pretreatment serum levels of vascular endothelial growth factor (VEGF) is associated with poor outcome in small cell lung cancer. Int J Cancer (Pred Oncol) 1998; 79, 144-146.
-
(1998)
Int J Cancer (Pred Oncol)
, vol.79
, pp. 144-146
-
-
Salven, P.1
Routsalainen, T.2
Mattson, K.3
Joensuu, H.4
-
22
-
-
2342552497
-
Vascular endothelial growth factor is associated with poor outcome in non-Hodgkin's lymphoma
-
Crew JP, O'Brien T, Bradburn M, et al. Vascular endothelial growth factor is associated with poor outcome in non-Hodgkin's lymphoma. Blood 1997; 90, 3167-3172.
-
(1997)
Blood
, vol.90
, pp. 3167-3172
-
-
Crew, J.P.1
O'Brien, T.2
Bradburn, M.3
-
23
-
-
0031900272
-
Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer
-
Kumar H, Heer K, Lee P, et al. Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer. Clin Cancer Res 1998; 4, 1279-1285.
-
(1998)
Clin Cancer Res
, vol.4
, pp. 1279-1285
-
-
Kumar, H.1
Heer, K.2
Lee, P.3
-
24
-
-
0030664484
-
Vascular endothelial growth factor in squamous head and neck carcinoma: Expression and prognostic significance
-
Salven P, Heikkilä P, Anttonen A, et al. Vascular endothelial growth factor in squamous head and neck carcinoma: expression and prognostic significance. Mod Pathol 1997; 10, 1128-1133.
-
(1997)
Mod Pathol
, vol.10
, pp. 1128-1133
-
-
Salven, P.1
Heikkilä, P.2
Anttonen, A.3
-
25
-
-
0030829035
-
Enhanced expression of vascular endothelial growth factor in metastatic melanoma
-
Salven P, Heikkilä P, Joensuu H. Enhanced expression of vascular endothelial growth factor in metastatic melanoma. Br J Cancer 1997; 76, 930-934.
-
(1997)
Br J Cancer
, vol.76
, pp. 930-934
-
-
Salven, P.1
Heikkilä, P.2
Joensuu, H.3
-
26
-
-
0026742073
-
The lack of utility of a tumor marker panel in head and neck carcinoma. Squamous cell carcinoma antigen, carcinoembryonic antigen, lipid-associated sialic acid, and CA-125
-
Straka MB, Wagner RL, Johnson JT, et al. The lack of utility of a tumor marker panel in head and neck carcinoma. Squamous cell carcinoma antigen, carcinoembryonic antigen, lipid-associated sialic acid, and CA-125. Arch Otolaryngol 1992; 118, 802-805.
-
(1992)
Arch Otolaryngol
, vol.118
, pp. 802-805
-
-
Straka, M.B.1
Wagner, R.L.2
Johnson, J.T.3
-
27
-
-
0027483537
-
Tumor markers in the diagnosis and follow-up of head and neck cancer: Role of CEA, CA 19-9, SCC, TK, and dTTPase
-
Walther EK, Dahlmann N, Gorgulla HT Tumor markers in the diagnosis and follow-up of head and neck cancer: role of CEA, CA 19-9, SCC, TK, and dTTPase. Head & Neck 1993; 15, 203-235.
-
(1993)
Head & Neck
, vol.15
, pp. 203-235
-
-
Walther, E.K.1
Dahlmann, N.2
Gorgulla, H.T.3
-
28
-
-
0029055683
-
Prognostic value of TPS in patients with head and neck malignancies: Comparison with SCC
-
Molina R, Torres MD, Moragas M, et al. Prognostic value of TPS in patients with head and neck malignancies: comparison with SCC. Anticancer Res 1995; 15, 479-484.
-
(1995)
Anticancer Res
, vol.15
, pp. 479-484
-
-
Molina, R.1
Torres, M.D.2
Moragas, M.3
-
29
-
-
0027437509
-
Intratumoral microvessel density and p53: Correlation with metastasis in head-and-neck squamous-cell carcinoma
-
Gasparini G, Weidner N, Maluta S, et al. Intratumoral microvessel density and p53: correlation with metastasis in head-and-neck squamous-cell carcinoma. Int J Cancer 1993; 55, 739-744.
-
(1993)
Int J Cancer
, vol.55
, pp. 739-744
-
-
Gasparini, G.1
Weidner, N.2
Maluta, S.3
-
30
-
-
0030874710
-
Tissue polypeptide specific antigen (TPS) detects a specific epitope structure on human cytokeratin
-
Einarsson R, Rydlander L. Tissue polypeptide specific antigen (TPS) detects a specific epitope structure on human cytokeratin. Anticancer Res 1997; 17, 312-314.
-
(1997)
Anticancer Res
, vol.17
, pp. 312-314
-
-
Einarsson, R.1
Rydlander, L.2
-
31
-
-
0027359953
-
Vascular permeability factor (VPF, VEGF) in tumor biology
-
Senger DR, van de Water L, Brown LF, et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer & Metastasis Rev 1993; 12, 303-324.
-
(1993)
Cancer & Metastasis Rev
, vol.12
, pp. 303-324
-
-
Senger, D.R.1
Van De Water, L.2
Brown, L.F.3
-
32
-
-
0031889548
-
Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: Significance for measurements and cancer biology
-
Banks RE, Forbes MA, Kinsey SE, et al. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for measurements and cancer biology. Br J Cancer 1998; 77, 956-964.
-
(1998)
Br J Cancer
, vol.77
, pp. 956-964
-
-
Banks, R.E.1
Forbes, M.A.2
Kinsey, S.E.3
-
33
-
-
0031775790
-
Circulating vascular endothelial growth factor (VEGF) is a possible tumor marker for metastasis in human hepatocellular carcinoma
-
Jin-No K, Tanimizu M, Hyodo I, et al. Circulating vascular endothelial growth factor (VEGF) is a possible tumor marker for metastasis in human hepatocellular carcinoma. J Gastroenterol 1998; 33, 376-380.
-
(1998)
J Gastroenterol
, vol.33
, pp. 376-380
-
-
Jin-No, K.1
Tanimizu, M.2
Hyodo, I.3
-
34
-
-
0031879683
-
Independent expression of serum vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in patients with carcinoma and sarcoma
-
Linder C, Linder S, Munck-Vikland E, Strander H. Independent expression of serum vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in patients with carcinoma and sarcoma. Anticancer Res 1998; 18, 2063-2068.
-
(1998)
Anticancer Res
, vol.18
, pp. 2063-2068
-
-
Linder, C.1
Linder, S.2
Munck-Vikland, E.3
Strander, H.4
|